4.6 Article

A Glucosylceramide Synthase Inhibitor Protects Rats Against the Cytotoxic Effects of Shiga Toxin 2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Therapeutic strategies for Shiga toxin-producingEscherichia coliinfections

Trisha J Rogers et al.

Expert Review of Anti-Infective Therapy (2009)

Article Pediatrics

Development of an experimental hemolytic uremic syndrome in rats

Elsa Zotta et al.

PEDIATRIC NEPHROLOGY (2008)

Article Pharmacology & Pharmacy

Monovalent Gb3-/Gb2-derivatives conjugated with a phosphatidyl residue:: A novel class of Shiga toxin-neutralizing agent

Paola Neri et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)

Article Endocrinology & Metabolism

A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease

Kerry Anne McEachern et al.

MOLECULAR GENETICS AND METABOLISM (2007)

Article Medicine, General & Internal

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children - A randomized controlled trial

H Trachtman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Immunology

Development of DNA vaccines against hemolytic-uremic syndrome in a murine model

AVE Capozzo et al.

INFECTION AND IMMUNITY (2003)

Review Biochemistry & Molecular Biology

Combinatorial ganglioside biosynthesis.

T Kolter et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Pediatrics

Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome

PE Ray et al.

PEDIATRIC NEPHROLOGY (2001)

Article Medicine, Research & Experimental

Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation

A Abe et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)